A groundbreaking new study spearheaded by researchers at Mass General Brigham has unveiled compelling evidence supporting the clinical utility of the McCance Brain Care Score (BCS) as a powerful predictor of cerebrovascular event risk in middle-aged women. This research, published in the esteemed journal Neurology, outlines a robust correlation between higher BCS scores and significantly reduced incidence of stroke and transient ischemic attacks (TIA), conditions that interrupt blood flow to the brain and represent some of the leading causes of morbidity and mortality worldwide.

The McCance Brain Care Score is an innovative composite metric that integrates 12 modifiable factors divided into three major domains: physical health measures, lifestyle behaviors, and social-emotional well-being indicators. Physical parameters include critical biomarkers such as blood pressure, blood glucose, cholesterol concentrations, and body mass index, whereas lifestyle components encompass smoking habits, alcohol consumption, diet quality, sleep regularity, and physical activity levels. Importantly, social-emotional factors assess the quality of interpersonal relationships, perceived stress, and an individual’s sense of purpose and meaningfulness in life, recognizing the multifaceted influences on cerebrovascular health.

Led by Dr. Nirupama Yechoor, MD, MSC, of Massachusetts General Hospital’s Department of Neurology—a key member institution within the Mass General Brigham integrated healthcare system—the team leveraged longitudinal data from the Women’s Health Study (WHS). This extensive clinical trial, renowned for its vast cohort and rigorous design, initially aimed to evaluate aspirin and vitamin E’s impact on cardiovascular and cancer outcomes in women. From a population of over 21,000 female participants with a median age just shy of 58, the investigators meticulously calculated baseline BCS values and tracked cerebrovascular event occurrences across more than two decades.

Their data reveal that each incremental increase of five points in the baseline BCS, around the cohort’s mean of 15 points, corresponds with a remarkable 37% reduction in the risk of experiencing either a stroke or transient ischemic attack during the follow-up timeline. This finding remained robust after adjusting for confounding variables including age, menopausal status, hormone replacement therapy, and an array of cardiovascular disease risk factors, emphasizing the BCS as an independent and reliable prognostic tool.

Stroke remains a formidable public health challenge, especially among women aged 55 to 75, where epidemiological estimates highlight that approximately 20% of this demographic are projected to suffer from cerebrovascular events during their lifetime. Prior investigations hinted at the predictive validity of the BCS in general populations for neurodegenerative diseases and affective disorders, but this study crucially establishes its focused applicability in middle-aged women, a group often underserved in stroke risk assessments.

The multidimensional nature of the BCS underscores the interconnectedness of varied physiological and psychosocial components underlying brain vascular health. Elevated blood pressure, dysregulated blood glucose, and undesirable lipid profiles create a biological milieu conducive to atherogenesis and cerebrovascular compromise. Simultaneously, unhealthy lifestyle practices such as smoking and physical inactivity exacerbate vascular insult, while stressful social environments and a low sense of life meaning may activate neuroendocrine pathways detrimental to cerebral circulation.

By harnessing the robust data from the Women’s Health Study, the researchers were able to conduct sophisticated statistical analyses with long-term follow-up, lending significant weight to their conclusions. The study’s strength lies in its comprehensive adjustment for potential confounders and its focus on modifiable factors, which inherently suggest actionable targets for preventive strategies and personalized interventions aimed at mitigating women’s stroke risk.

Dr. Devanshi Choksi, MBBS, MPH, as lead author and research fellow at MGH’s Neurology Department, highlights the study’s broader implications for public health. She emphasizes the potential for the McCance Brain Care Score to not only stratify risk at a population level but also to serve as a dynamic marker reflecting changes in lifestyle and health status over time. This opens avenues for continuous monitoring and tailored therapeutic approaches that may ultimately reduce the burden of cerebrovascular diseases.

The study’s comprehensive authorship team, consisting of experts in neurology, epidemiology, and brain health from Mass General Brigham and Harvard-affiliated institutions, showcases multidisciplinary collaboration essential for advancing translational research. Moreover, the study was generously funded by multiple prestigious entities including the Lavine Brain Health Innovation Fund, the American Heart Association, and the National Institutes of Health, underscoring the high regard and importance of research in cerebrovascular risk prediction.

It is notable that the McCance BCS offers an accessible framework based on measurable and modifiable factors, making it a practical tool for clinicians in varied healthcare settings aiming to integrate evidence-based risk stratification into routine care. Unlike complex genetic or imaging biomarkers which may impose financial or logistical barriers, the BCS’s incorporation of widely available clinical and lifestyle data could facilitate widespread adoption and scalable preventive strategies.

Looking ahead, the research team calls for expanded studies across more ethnically and socioeconomically diverse populations to validate and refine the McCance Brain Care Score’s predictive scope. Understanding how longitudinal fluctuations in the score reflect evolving stroke risk could revolutionize personalized medicine paradigms and inform public health campaigns centered on brain health preservation.

Overall, this pioneering research marks a significant stride forward in cerebrovascular disease prevention in women, aligning with global health priorities targeting stroke reduction. As cerebrovascular events continue to impose profound individual and societal costs, tools like the McCance Brain Care Score provide hope for earlier identification, effective intervention, and ultimately, enhanced quality of life through stroke risk mitigation.

Subject of Research: People

Article Title: Use of the Brain Care Score to Estimate the Risk of Incident Cerebrovascular Events in Middle-Aged Women

News Publication Date: 16-May-2025

Web References:

• https://www.massgeneralbrigham.org/
• https://www.neurology.org/doi/10.1212/WNL.0000000000213674
• https://whs.bwh.harvard.edu/

References:
Choksi, D. et al. “Use of the Brain Care Score to Estimate the Risk of Incident Cerebrovascular Events in Middle-Aged Women” Neurology DOI: 10.1212/WNL.0000000000213674

Keywords:
Vascular diseases, Central nervous system, Brain, Risk factors, Neurology